triptolide has been researched along with Non-alcoholic Fatty Liver Disease in 1 studies
| Timeframe | Studies, this research(%) | All Research% |
|---|---|---|
| pre-1990 | 0 (0.00) | 18.7374 |
| 1990's | 0 (0.00) | 18.2507 |
| 2000's | 0 (0.00) | 29.6817 |
| 2010's | 0 (0.00) | 24.3611 |
| 2020's | 1 (100.00) | 2.80 |
| Authors | Studies |
|---|---|
| Fu, P; Guo, F; Huang, R; Li, G; Li, Y; Liang, Y; Ma, L | 1 |
1 other study(ies) available for triptolide and Non-alcoholic Fatty Liver Disease
| Article | Year |
|---|---|
Activation of AMPK by triptolide alleviates nonalcoholic fatty liver disease by improving hepatic lipid metabolism, inflammation and fibrosis.
Topics: AMP-Activated Protein Kinases; Animals; Diterpenes; Epoxy Compounds; Inflammation; Lipid Metabolism; Lipids; Liver; Liver Cirrhosis; Mice; Mice, Inbred C57BL; Molecular Docking Simulation; Non-alcoholic Fatty Liver Disease; Phenanthrenes | 2021 |